İnflamatuar Olmayan Benign Anorektal Hastalıkların Tedavisinde Topikal Kremlerin Kullanımı
Özet
Bu metin, benign anorektal hastalıkların (hemoroid ve anal fissür gibi) tedavisinde kullanılan topikal kremlerin farmakolojik özelliklerini, etki mekanizmalarını ve klinik etkinliğini kapsamlı bir şekilde incelemektedir. Yazıda, rektal yolun oral yola alternatif olarak sunduğu düşük enzimatik aktivite ve hepatik ilk geçiş etkisini azaltma gibi avantajlar vurgulanmakta; nitratlar (gliseriltrinitrat), kalsiyum kanal blokörleri (diltiazem, nifedipin), antispazmodikler ve topikal analjezikler (lidokain) gibi temel ilaç grupları detaylandırılmaktadır. Ayrıca tribenozid-lidokain kombinasyonunun yara iyileştirici etkisine, kortikosteroidlerin inflamasyon üzerindeki rolüne ve minoksidil, aloe vera gibi alternatif tedavilerin etkinliğine değinilmektedir. Sonuç olarak, bu topikal ajanların cerrahi öncesi ve sonrası dönemde semptomları gidermede, ağrıyı azaltmada ve "kimyasal sfinkterotomi" sağlamada güçlü birer seçenek olduğu; ancak kalıcı iyileşme ve nüksü önleme için yaşam tarzı değişiklikleriyle desteklenmeleri gerektiği belirtilmektedir.
This text comprehensively examines the pharmacological properties, mechanisms of action, and clinical efficacy of topical creams used in the treatment of benign anorectal diseases such as hemorrhoids and anal fissures. The study emphasizes the advantages of the rectal route over the oral route, such as lower enzymatic activity and reduction of the hepatic first-pass effect, while detailing primary drug groups including nitrates (glyceryl trinitrate), calcium channel blockers (diltiazem, nifedipine), antispasmodics, and topical analgesics (lidocaine). Furthermore, it addresses the wound-healing effects of the tribenoside-lidocaine combination, the role of corticosteroids in reducing inflammation, and the effectiveness of alternative treatments like minoxidil and aloe vera. Ultimately, the text concludes that these topical agents are powerful treatment modalities for alleviating symptoms, reducing pain, and providing "chemical sphincterotomy" in both pre- and post-operative periods; however, it notes that they must be supported by lifestyle changes to achieve lasting recovery and prevent recurrence.
Referanslar
Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol. 2019;10:1-16.
Ottaiano R, Sebastiano M, Bondarenko LB, et al. Pharmacokinetic Characteristics of a Nifedipine and Lidocaine Fixed Combination in the Form of Rectal Cream: Two Decades Data Analysis. 2021;5 (1):27-36.
Turner C, Aye Mya Thein N, Turner P, et al. Rectal pH in well and unwell infants. J Trop Pediatr. 2012;58 (4):311–3.
Jannin V, Lemagnen G, Gueroult P, et al. Rectal route in the 21st Century to treat children. Adv Drug Deliv Rev. 2014;73:34–49.
Shafik A, Mostafa RM, Shafik I, et al. Functional activity of the rectum: A conduit organ or a storage organ or both? World J Gastroenterol WJG. 2006;12 (28):4549-52.
Leppik IE, Patel SI. Intramuscular and rectal therapies of acute seizures. Epilepsy Behav. 2015;49:307–12.
De Boer AG, Moolenaar F, De Leede LGJ, et al. Rectal drug administration. Clin Pharmacokinet. 1982;7 (4):285–311.
van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, part I. Clin Pharmacokinet. 1991;21 (2):11–26.
Nunes R, Sarmento B, das Neves J. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges. J Controlled Release. 2014;194:278–94.
Purohit TJ, Hanning SM, Wu Z. Advances in rectal drug delivery systems. Pharm Dev Technol. 2018;23 (10):942–52.
Reinus, JF., Simon, D. (2014). Gastrointestinal anatomy and physiology: the essentials. John Wiley & Sons.
Dujovny N, Quiros RM, Saclarides TJ. Anorectal anatomy and embryology. Surg Oncol Clin. 2004;13 (2):277–93.
Herliczek TW, Swenson DW, Mayo-Smith WW. Utility of MRI after inconclusive ultrasound in pediatric patients with suspected appendicitis: retrospective review of 60 consecutive patients. Am J Roentgenol. 2013;200 (5):969–73.
Shreya AB, Raut SY, Managuli RS, et al. Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances. AAPS PharmSciTech. 2019;20 (1):1–12.
Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42 (6):620–43.
Homayun B, Lin X, Choi H-J. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;129 (3):1-29.
Brunton, LL., Chabner, B., Knollmann, BC. (2018). Goodman & Gilman’s the pharmacological basis of therapeutics. McGraw-Hill Education New York, NY, USA.
Watson SJ, Kamm MA, Nicholls RJ, et al. Topical glyceryl trinitrate in the treatment of chronic anal fissure. J Br Surg. 1996;83 (6):771–5.
Shrestha SK, Thapa PB, Maharjan DK, et al. Effectiveness of 0.2% glyceryl trinitrate and 0.5% nifedipine in the treatment of chronic anal fissure. J Nepal Med Assoc. 2017;56 (205):149–52.
Bansal AR, Yadav PK, Godara R, et al. Comparative evaluation of 0.2% glyceryl trinitrate vs. 2% diltiazem ointment in treatment of chronic anal fissure treatment-a randomized trial. Hell J Surg. 2016;88 (1):25–30.
Haider SB, Khan MTJ, Mahesar SA, et al. Comparison of lateral anal spincterotomy and 0.2% Glyceryl trinitrate (GTN) in the treatment of chronic anal fissure. Pak J Surg. 2020;36 (4):292–8.
Dorfman G, Levitt M, Platell C. Treatment of chronic anal fissure with topical glyceryl trinitrate. Dis Colon Rectum. 1999;42 (8):1007–10.
Nelson RL, Thomas K, Morgan J, et al. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012 (2);2:1-136.
Jin JZ, Hardy M-O, Unasa H, et al. A systematic review and meta-analysis of the efficacy of topical sphincterotomy treatments for anal fissure. Int J Colorectal Dis. 2021;1–15.
Jonas M, Neal KR, Abercrombie JF, et al. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum. 2001;44 (8):1074–8.
Carapeti EA, Kamm MA, Evans BK, et al. Topical diltiazem and bethanechol decrease anal sphincter pressure without side effects. Gut. 1999;45 (5):719–22.
Nevins EJ, Kanakala V. Topical diltiazem and glyceryl-trinitrate for chronic anal fissure: A meta-analysis of randomised controlled trials. Turk J Surg. 2020;36 (4):347-52.
Ala S, Saeedi M, Hadianamrei R, et al. Topical diltiazem vs. topical glyceril trinitrate in the treatment of chronic anal fissure: a prospective, randomized, double-blind trial. Acta Gastro Enterol Belg. 2012;75 (4):438-42.
Antropoli C, Perrotti P, Rubino M, et al. Nifedipine for local use in conservative treatment of anal fissures: Preliminary results of a multicenter study. Dis Colon Rectum. 1999 Aug;42 (8):1011–5.
Perrotti P, Antropoli C, Molino D, et al. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Colon Rectum. 2001 Mar;44 (3):405–9.
Jabbar L. THE COMPARATIVE STUDY BETWEEN THE TOPICAL PREPARATIONS OF DILTIAZEM VERSUS THE NIFEDIPINE IN TREATMENT OF ANAL FISSURE. IJPR. 2018;45 (1):21-4.
Kujur ADS, Ekka NMP, Chandra S, et al. Comparative study to assess the effectiveness of topical Nifedipine and Diltiazem in the treatment of chronic anal fissure. J Fam Med Prim Care. 2020;9 (11):5652-7.
Ottaiano R, Sebastiano M, Bondarenko LB, et al. Pharmacokinetic Characteristics of a Nifedipine and Lidocaine Fixed Combination in the Form of Rectal Cream: Two Decades Data Analysis. 2021;5 (1):27-36.
Yamato S, Rattan S. Role of alpha adrenoceptors in opossum internal anal sphincter. J Clin Invest. 1990;86 (2):424-429.
Pitt J, Dawson PM, Hallan RI, et al. A double-blind randomized placebo-controlled trial of oral indoramin to treat chronic anal fissure. Colorectal Dis. 2001;3 (3):165–8.
Pitt J, Craggs MM, Henry MM, et al. Alpha-1 adrenoceptor blockade: potential new treatment for anal fissures. Dis Colon Rectum. 2000 Jun;43 (6):800–3.
Nagasaki M, Komori S, Ohashi H. Effect of trimebutine on voltage-activated calcium current in rabbit ileal smooth muscle cells. Br J Pharmacol. 1993;110 (1):399–403.
Ho YH, Seow-Choen F, Low JY, et al. Randomized controlled trial of trimebutine (anal sphincter relaxant) for pain after haemorrhoidectomy. J Br Surg. 1997;84 (3):377–9.
Kundra P, Vinayagam S. Perioperative intravenous lidocaine: Crossing local boundaries and reaching systemic horizons. Indian J Anaesth. 2020 May;64 (5):363–5.
Thomson PD, Melmon KL, Richardson JA, et al. Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans. Ann Intern Med. 1973;78 (4):499-508.
Friskopp J, Huledal G. Plasma levels of lidocaine and prilocaine after application of Oraqix®, a new intrapocket anesthetic, in patients with advanced periodontitis. J Clin Periodontol. 2001;28 (5):425–9.
Collinsworth KA, Kalman SM, Harrison DC. The Clinical Pharmacology of Lidocaine as an Antiarrhythymic Drug. Circulation. 1974 Dec;50 (6):1217–30.
Conklin KA. Pharmacology of local anesthetics. AANA J. 1987 Feb;55 (1):36–44.
Cousins MJ, Mather LE. Clinical pharmacology of local anaesthetics. Anaesth Intensive Care. 1980;8 (3):257–77.
Svensson P, Bjerring P, Arendt-Nielsen L, et al. Hypoalgesic effect of EMLA and lidocaine gel applied on human oral mucosa: quantitative evaluation by sensory and pain thresholds to argon laser stimulation. Anesth Prog. 1992;39 (1-2):4-8.
de Boer AG, Breimer DD, Mattie H, et al. Rectal bioavailability of lidocaine in man: Partial avoidance of “first-pass” metabolism. Clin Pharmacol Ther. 1979 Dec;26 (6):701–9.
Zimmermann J, Schlegelmilch R, Mazur D, et al. Proof of Systemic Safety of a Lidocaine Ointment in the Treatment of Patients with Anorectal Pain. Arzneimittelforschung. 2007 Jan;57 (1):12–9.
Barash M, Reich KA, Rademaker D. Lidocaine-Induced Methemoglobinemia: A Clinical Reminder. J Osteopath Med. 2015 Feb 1;115 (2):94–8.
Kikkawa Y, Takaki S, Matsuda Y, et al. The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells. Biol Pharm Bull. 2010;33 (2):307–10.
Jaques R. The pharmacological activity of tribenoside. Pharmacology. 1977;15 (5):445–60.
Lorenc Z, Gökçe Ö. Tribenoside and lidocaine in the local treatment of hemorrhoids: an overview of clinical evidence. Eur Rev Med Pharmacol Sci. 2016;20 (12):2742–51.
Havlickova B. Topical corticosteroid therapy in proctology indications. Aliment Pharm Ther. 2010;31 (1):19–32.
Goren A, Shapiro J, Roberts J, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther. 2015;28 (1):13–6.
Muthukumarassamy R, Robinson SS, Sarath SC, et al. Treatment of anal fissures using a combination of minoxidil and lignocaine: a randomized, double-blind trial. Indian J Gastroenterol Off J Indian Soc Gastroenterol. 2005;24 (4):158–60.
Alvandipour M, Ala S, Khalvati M, et al. Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. World J Surg. 2018 Jul;42 (7):2252–8.
Awan NA, Mir IN, Wani HA, et al. Comparison of topical agents minoxidil and diltiazem in medical management of anal fissures: a hospital based study. 2017 Nov 25;4 (12):3939–42.
Emile SH, Abdel-Razik MA, Elshobaky A, et al. Topical 5% minoxidil versus topical 0.2% glyceryl trinitrate in treatment of chronic anal fissure: A randomized clinical trial. Int J Surg. 2020 Mar;75:152–8.
McKee HR, Abou-Khalil B. Outpatient Pharmacotherapy and Modes of Administration for Acute Repetitive and Prolonged Seizures. CNS Drugs. 2015 Jan;29 (1):55–70.
Hang MTH, Smith BE, Keck C, et al. Increasing efficacy and reducing side effects in treatment of chronic anal fissures. Medicine (Baltimore). 2017 May 19;96 (20):e6853.
Keyhanian S, Stahl-Biskup E. Phenolic Constituents in Dried Flowers of Aloe vera ( Aloe barbadensis ) and their in vitro Antioxidative Capacity. Planta Med. 2007 Jun;73 (6):599–602.
Prakoso YA, Kurniasih. The Effects of Aloe vera Cream on the Expression of CD4+ and CD8+ Lymphocytes in Skin Wound Healing. J Trop Med. 2018 Feb 15;2018:6218303.
Dámaso Fernández-Ginés F, Cortiñas-Sáenz M, Mateo-Carrasco H, et al. Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers. Am J Health Syst Pharm. 2017 May 1;74 (9):e176–82.
Martínez-Monsalve A, Selva-Sevilla C, Gerónimo-Pardo M. Analgesic effectiveness of topical sevoflurane to perform sharp debridement of painful wounds. J Vasc Surg. 2019 May;69 (5):1532–7.
Cifuentes-Tébar J, Rueda-Martínez JL, Selva-Sevilla C, et al. Analgesic Effectiveness and Improvement in Quality of Life after Using Topical Sevoflurane for an Extremely Painful Anal Fissure. J Coloproctology. 2021 Jun;41:206–9.
Mosleh G, Badr P, Abolhassanzadeh Z, et al. Potential Effects and Mechanisms of Action of Topical Wallflower (Erysimum cheiri (L.) Cranz) Administration in Anal Fissure.RJP. 2019;6 (1):63-9.
Gurel E, Ustunova S, Ergin B, et al. Herbal haemorrhoidal cream for haemorrhoids. Chin J Physiol. 2013 Oct 31;56 (5):253–62.
